The trials and tribulations of IL-5, eosinophils, and allergic asthma.
about
Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodelingType 2 innate lymphoid cells: at the cross-roads in allergic asthmaEffects of prednisone on eosinophilic bronchitis in asthma: a systematic review and meta-analysisSevere asthma: anti-IgE or anti-IL-5?Personalized Medicine in AllergyA possible link between sinusitis and lower airway hypersensitivity: the role of Staphylococcal enterotoxin BEosinophils in fungus-associated allergic pulmonary diseaseIs IL-10 a good target to inhibit choroidal neovascularisation in age-related macular disease?Recent progress in the pharmacotherapy of Churg-Strauss syndrome.Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukastNew targets for allergic rhinitis--a disease of civilization.Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models.Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases.Intranasal Administration of Recombinant Mycobacterium smegmatis Inducing IL-17A Autoantibody Attenuates Airway Inflammation in a Murine Model of Allergic AsthmaThe eosinophil enigmaEosinophils in the pathogenesis of allergic airways disease.Multi-dimensional phenotyping: towards a new taxonomy for airway disease.Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?Anti-interleukin-5 antibody therapy in eosinophilic diseases.A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma.trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulationMechanisms of Disease of Eosinophilic Esophagitis.Targeting eosinophils in asthmaFunctionally competent eosinophils differentiated ex vivo in high purity from normal mouse bone marrow.TEC and MAPK Kinase Signalling Pathways in T helper (TH) cell Development, TH2 Differentiation and Allergic Asthma.Allergy and the lung.Airway hyperresponsiveness in the absence of CD4+ T cells after primary but not secondary challengePneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6.CCR3 antagonists: a survey of the patent literature.Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract.Use of biologicals as immunotherapy in asthma and related diseases.Hypereosinophilic syndromes and new therapeutic approaches including anti-IL-5.Tryptase as an inflammatory marker in allergic disease and asthma.What's new in asthma pathophysiology and immunopathology?Th2 cytokine antagonists: potential treatments for severe asthma.Allergic mechanisms in eosinophilic esophagitis.Blood eosinophils as a marker of likely corticosteroid response in children with preschool wheeze: time for an eosinophil guided clinical trial?The Use of Mouse Asthma Models to Successfully Discover and Develop Novel Drugs.
P2860
Q24645925-32832DF4-9CA2-4673-9BCE-405768BFBD0EQ26766464-5E9079C6-2AAE-4D76-A6D1-9BE1FECFC5D5Q26825266-DF485452-CE82-4D4F-B7E8-ADD5EE913B50Q28071832-FA168363-8A92-404F-B7C7-682E2EBC5295Q28073074-89D77D8B-0CE4-491E-B2D4-4893E464B10BQ28217598-2095F1A4-0095-403A-A606-1BBB381E139DQ28393919-EBDD0F59-E6B2-4906-B1D8-64463776D9D7Q33253662-DF29010E-F507-4320-9949-3EBA1E87642BQ33974627-562DDCF0-B2D9-42F2-A624-BD95C4155433Q35016089-E74E88D1-4A29-479D-9545-7FC75676E825Q35537471-AA73387A-6D00-4EDB-A3FB-5258E0B3BA98Q35605442-9F893BE6-8FF4-4180-AA6B-0091AB724C39Q35627697-395A5401-8C9A-4322-A28C-2F3C7AF50BEDQ35928530-4A4DD192-A8C6-4D3E-AF56-25DCEDEB9AF9Q35956060-2EFAE318-143E-42EF-877F-BB4D54FB43C4Q36057112-202B9B5E-9978-4114-BE2F-26815D8DDF10Q36059786-72EBF613-DC0F-413E-81A9-2A34BB2131D9Q36292293-7C3E128B-78F5-4742-B797-96E77B4A3E4AQ36334083-9A178225-D017-4DE2-AF7F-8A29016D1674Q36376519-C9705F22-D232-4FA5-A81E-1B025C1043BBQ36438486-DC8337E1-4942-47F2-A527-AEC5AD90C989Q36700648-60DA5403-B85F-4A7F-8E92-52534DDAF455Q37002367-A5742485-263D-4A6E-9021-CC4788F96EA2Q37031313-B6F47F51-5AD6-4282-82D8-C6008D6379FFQ37056577-C71B7787-9563-46BB-ADE8-5AA7DFE0840BQ37187744-AD0B9D5A-978A-4742-BBF4-2365C944F647Q37219806-C419C21B-2AF9-4395-9A34-CD5737977D8CQ37249794-01E5179E-D664-4649-B8FD-A623744C6BF0Q37273826-07370D1A-E1D4-4A94-B420-08AAAFED270CQ37372816-153DC553-D83E-43EC-8FF3-89E8E273C35FQ37564516-9D95031D-FEDD-4792-B91C-D22D4E86FFBFQ37731037-0CF41280-9CBD-4394-BE69-9DB2279A054AQ37754792-1DCC3481-518B-468C-9A42-BAF5236847B1Q37755233-CD0E66F4-7F89-42A8-8DFB-E148B95F6FEFQ37755301-F8B66248-FC37-4AD2-BFAC-F9C26DA7B265Q37798030-70BEF08A-694E-41E5-BD0C-170C03A51E69Q38057796-188A9093-CC0C-4E72-84F1-907DD1D51643Q38210618-AA061367-816F-4194-A951-166DAFC512C2Q38391330-49A67619-4D00-4954-A544-4F4D4EAFA09DQ38740613-9C585D6E-B3E6-48DE-89C1-B2D05A07D697
P2860
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@ast
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@en
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@nl
type
label
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@ast
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@en
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@nl
prefLabel
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@ast
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@en
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@nl
P2093
P356
P1476
The trials and tribulations of IL-5, eosinophils, and allergic asthma.
@en
P2093
O'Byrne PM
Parameswaran K
P304
P356
10.1067/MAI.2001.119149
P407
P577
2001-10-01T00:00:00Z